|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/575 | (2006.01) |
| A61P 25/28 | (2006.01) | ||
| C07J 9/00 | (2006.01) |
| (11) | Number of the document | 2968369 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14774060.9 |
| Date of filing the European patent application | 2014-03-13 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-29 |
| (46) | Date of publication of the claims translation | 2018-12-27 |
| (86) | Number | PCT/US2014/026784 |
| Date | 2014-03-13 |
| (87) | Number | WO 2014/160480 |
| Date | 2014-10-02 |
| (30) | Number | Date | Country code |
| 201361779735 P | 2013-03-13 | US |
| (72) |
MARTINEZ BOTELLA, Gabriel, US
HARRISON, Boyd, L., US
ROBICHAUD, Albert, J., US
SALITURO, Francesco, G., US
|
| (73) |
Sage Therapeutics, Inc.,
215 First Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Neuroaktyvūs steroidai ir jų panaudojimo būdai |
| NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-02-24 | 12 | 289.00 EUR |
| 2026-03-13 |